|1.||Ferrone, Soldano: 12 articles (04/2012 - 05/2003)|
|2.||Seliger, Barbara: 6 articles (05/2013 - 05/2003)|
|3.||Thuring, Camilla: 4 articles (12/2015 - 01/2014)|
|4.||Paulsson, Kajsa M: 3 articles (12/2015 - 01/2014)|
|5.||Geironson, Linda: 3 articles (12/2015 - 01/2014)|
|6.||Ogino, Takeshi: 3 articles (04/2010 - 09/2003)|
|7.||Harabuchi, Yasuaki: 3 articles (04/2010 - 09/2003)|
|8.||Jefferies, Wilfred A: 3 articles (12/2008 - 09/2005)|
|9.||Atkins, Derek: 3 articles (09/2005 - 05/2003)|
|10.||Garrido, Federico: 3 articles (02/2005 - 09/2003)|
|1.||Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/01/2011 - "In this study, we investigated the expression of TAP-1 and tapasin in oral squamous cell carcinoma (OSCC); the result indicated significant down-regulation in the expression of these genes. "
10/01/2010 - "The aim of this study was to investigate the expression of tapasin in primary oral squamous cell carcinoma (OSCC) and its potential clinical implication. "
10/01/2010 - "Downregulation of tapasin expression in primary human oral squamous cell carcinoma: association with clinical outcome."
02/02/2001 - "Using the reverse transcription PCR, we evaluated expression levels of various antigen presentation-related genes, including LMP2, LMP7, MECL-1, PA28alpha, PA28beta, TAP1, TAP2, and tapasin, in two oral squamous cell carcinoma cell lines, HSC5 and HSC7. "
09/01/2011 - "To investigate the expression of antigen processing-1 (Tap-1) and Tapasin in oral squamous cell carcinoma (OSCC), and observe the immune response against OSCC by use of IFN-γ-antigen induced dendritic cells (DCs) in vitro and in vivo. "
|2.||Melanoma (Melanoma, Malignant)
05/01/2008 - "In this study, we take advantage of a human melanoma cell line in which TAP can be induced, but tapasin cannot. "
05/01/2008 - "In this study, we show that treatment with HDACi enhances the expression of molecules (TAP1, TAP2, LMP2, LMP7, Tapasin and MHC class I) involved in antigen processing and presentation via the MHC class I pathway in melanoma cells. "
10/01/2010 - "Here, we report on an alternate splice form of tapasin (tpsnΔEx3) derived from a human melanoma cell line that does not appear to be caused by mutations. "
10/01/2010 - "Identification of an alternate splice form of tapasin in human melanoma."
06/01/2003 - "Whereas 100% of melanomata in situ and 96.2% of primary melanomas with a Breslow index of <or=0.75 mm showed strong expression of tapasin, significant downregulation of tapasin was observed in 25% of primary melanomas with a Breslow index >0.75 mm as well as in 21.1% metastatic melanoma lesions. "
03/01/2008 - "The aim of this study is to examine if Tapasin (Tpn) plays a critical role in the escape of tumors from immunologic recognition. "
01/01/2015 - "Consistent with published functional data showing that tapasin promotes antigen presentation, as well as tumor immune recognition and destruction by CD8(+) CTLs, a reduction in tapasin expression is associated with tumor progression in CRC."
04/01/2012 - "There was a different expression pattern among cancer cell lines for HLA class I heavy chain (HLA-HC), β2 microglobulin, Tapasin, TAP-1, TAP-2, LMP-7 and LMP-10. "
10/01/2010 - "Lack of tapasin expression was observed in 30 of 67 (43%) tumors and was significantly associated with poor pathologic differentiation grade of OSCC (P = 0.028). "
03/01/2008 - "Combining the antigen processing components TAP and Tapasin elicits enhanced tumor-free survival."
01/01/2015 - "Our study implicated that TAP2, HLA-DOA, HLA-DOB, and tapasin loci were novel candidate regions for susceptibility to HCV infection and viral clearance in the Chinese population. "
05/01/2014 - "Overall this work demonstrates the induction of tapasin protein by dsRNA stimulation, which implies its possible conserved regulation during viral infection in teleost cells."
09/01/2013 - "In a European, but not a US, Caucasian population, the tapasin G allele was significantly associated with the outcome of HCV infection, being found in 82.5% of resolvers versus 71.3% of persistently infected individuals (P = 0.02, odds ratio [OR] = 1.90 95% confidence interval [CI] = 1.11-3.23). "
09/01/2013 - "Patients with resolved or chronic HCV infection were genotyped for the known G/C coding polymorphism in exon 4 of the tapasin gene. "
08/01/2006 - "We show in this report that JEV infection of mouse brain astrocytes results in induction of the nonclassical MHC Class Ib genes, H-2T23, H-2Q4 and H-2T10 in addition to MHC-I, Type I (alpha/beta) IFNs, TAP-1, TAP-2, Tapasin, LMP-2, LMP-7 and LMP-10 but not IFNgamma, CD80, CD86 and MHC-II genes. "
|5.||Small Cell Lung Carcinoma (Small Cell Lung Cancer)
09/01/2005 - "The present study examines the expression of HLA, tapasin, transporter associated with antigen processing 1 (TAP1), and beta2 microglobulin in human small cell lung carcinoma and non-small cell lung carcinoma. "
08/01/2007 - "Yet when these experiments were extended to tumour cell lines derived from small cell lung cancer (SCLC), which we show to be tapasin deficient in addition to TAP-negative, the TAP-, tapasin-independent peptides were not presented. "
01/01/2001 - "Heterogeneous and reduced expression levels of tapasin were found in small-cell lung carcinoma, pancreatic carcinoma, colon carcinoma, head an neck squamous cell carcinoma and renal cell carcinoma cell lines. "
|2.||transporter associated with antigen processing (TAP)
|5.||Proteins (Proteins, Gene)
|7.||Messenger RNA (mRNA)
|8.||Proteasome Endopeptidase Complex (Proteasome)
|10.||HLA-B Antigens (HLA-B)